Key result
Protocolized potassium management is linked to ~86% fewer concentrated IV potassium chloride doses.
Why the study?
IV potassium supplementation is commonly used in the pediatric cardiovascular ICU, but concentrated IV potassium chloride doses can lead to life-threatening complications. This quality improvement project aimed to decrease concentrated IV potassium chloride exposure.
Does a protocolized potassium management algorithm focused on early enteral supplementation decrease concentrated IV potassium chloride exposure and hyperkalemia in pediatric cardiac ICU patients?
Observational (n=443)
Does a protocolized potassium management algorithm focused on early enteral supplementation decrease concentrated IV potassium chloride exposure and hyperkalemia in pediatric cardiac ICU patients?
A protocolized potassium management strategy focused on early enteral supplementation safely reduced concentrated IV potassium chloride exposure and hyperkalemia in pediatric cardiac ICU patients without increasing arrhythmias.
Answers are grounded in this paper and cite their sources.
Supports cautious adoption of enteral-focused potassium protocols in pediatric cardiac ICU; leaves open need for randomized confirmation.
Objectives: IV potassium supplementation is commonly used in the pediatric cardiovascular ICU. However, concentrated IV potassium chloride doses can lead to life-threatening complications. We report results of a quality improvement project aimed at decreasing concentrated IV potassium chloride exposure. Design: Retrospective evaluation of a quality improvement project aimed at reducing IV potassium chloride exposure. Setting: Pediatric cardiac ICU. Patients: All patients admitted to pediatric cardiac ICUs in April 2013 to September 2013 (preprotocol) and October 2013 to April 2014 (postprotocol). Interventions: A quality improvement team developed a potassium protocol aimed at maintaining serum potassium levels 3.0–5.5 mEq/L, via algorithm focused on early enteral supplementation. All patients receiving IV diuretics who had a serum potassium level less than 4.5 mEq/L and urine output more than 0.5 mL/kg/hr had protocol initiated with potassium chloride–containing IV fluids or enteral potassium chloride. Concentrated IV potassium chloride infusions were limited to asymptomatic patients with serum potassium less than 2.0 mEq/L and high-risk patients at less than 3.0 mEq/L. Serum potassium levels were measured once daily, and protocolized adjustments were made based on this level and concurrent diuretic therapy. Measurements and Main Results: Serum potassium, potassium chloride supplementation, patient cost, fluid administration, and arrhythmia incidence were compared pre and post protocol. Four hundred forty-three admissions were included (234 pre protocol and 209 post protocol). No significant differences were found in demographics. There was no difference in mean morning serum potassium after protocol implementation (3.85 [0.77] mEq/L before protocol and 3.89 [0.75] mEq/L after protocol; p = 0.90). Concentrated IV potassium chloride administration was decreased by 86% (331 vs 47 doses). With protocol, there was decreased incidence in days with one measured episode of hyperkalemia (11 vs 4/1,000 patient-days; p = 0.02) and a trend toward decreased hypokalemia (433 vs 400/1,000 patient-days; p = 0.05). Arrhythmia incidence was similar (p = 0.59). Conclusions: Protocolized potassium management in pediatric cardiac intensive care patients decreased concentrated IV potassium chloride exposure and incidence of hyperkalemia. Lower potassium treatment threshold for IV potassium chloride was not associated with increased arrhythmias.
No takes yet. Share an insight, caveat, or question.
Rhodes et al. (2016) conducted an observational in Pediatric cardiac ICU admission requiring potassium supplementation (n=443). Protocolized potassium management focusing on early enteral supplementation vs. Pre-protocol standard care was evaluated on Concentrated IV potassium chloride administration and incidence of hyperkalemia (p=0.02). Protocolized potassium management decreased concentrated IV potassium chloride doses by 86% (47 vs 331) and hyperkalemia incidence.
Synapse has enriched 10 related papers. Consider them for comparative context: